EXUMA Biotech
Dr. Houston Holmes joined EXUMA as a Director in December, 2021. Dr. Holmes is a hematologist/oncologist at Texas Oncology, where he serves on the Board of Directors and Executive Committee, and he is Area Medical Director of the Baylor/Sammons Cancer Center in Dallas. His clinical focus is in research and development of cell therapies for cancer.
Dr. Holmes received a BS in medical microbiology from Stanford University School of Medicine, an MD from the University of Texas Southwestern Medical School, and an MBA from the University of Texas at Dallas. He completed an internship and residency in internal medicine at Baylor University Medical Center, and fellowship in medical oncology/hematology at the National Cancer Institute/National Heart, Lung, and Blood Institute.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
EXUMA Biotech
EXUMA Biotech is a clinical-stage biotechnology company committed to bringing to market CAR-T therapies for the treatment of cancer. Founded in 2015, the company has rapidly built its core technologies and a growing global presence with operations in China (Shanghai and Shenzhen), Grand Cayman, and across the US with sites in West Palm Beach and San Diego.